Skip to content

Study on Clinical Improvement in PCOS Patients Treated with Individualized Homoeopathic Medicines Considering Miasmatic States

A non - randomized observational study of individualized homoeopathic medicine in treatment of poly cystic ovary syndrome (PCOS) considering the miasmatic states - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110433
Enrollment
37
Registered
2026-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine. Potency, dose, and repetition will be decided according to patient susceptibility and principles of homoeopat

Sponsors

RBTS Government Homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of reproductive age groups of 14- 45 years 2. Females from all religion and socio- economic strata. 3. Patient satisfying the Rotterdam Criteria. 4. Subject willing to give written informed consent by participants and parents or guardians under 18 years. 5. No use of birth control pill for at least 3 months before the study. 6. Patient willing to undergo individualized homeopathic treatment and follow-up regularly for study duration.

Exclusion criteria

Exclusion criteria: 1. Age below 14 years and after 45 years. 2. patients on chemotherapy. 3. Patient suffering from any severe PID disease. 4. Pregnant, lactating (less than 6 months) and puerperal women. 5. Undergoing homoeopathic treatment for any chronic disease from other physician. 6. Patient unable to provide consent or commit to regular follow-up. 7. Simultaneously taking part in other clinical trials.

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of individualized homoeopathic medicines in patients of PCOS based on improvement in menstrual irregularities and associated clinical symptoms, assessed at baseline and end of study.Timepoint: 24 weeks

Secondary

MeasureTime frame
Secondary outcome measures will include assessment of changes in ultrasonographic findings, improvement in associated symptoms of Polycystic Ovary Syndrome such as acne, hirsutism, obesity and hair fall, along with evaluation of BMI and miasmatic correlation during the treatment period.Timepoint: 24 weeks

Countries

India

Contacts

Public ContactDr Supriya Preetam

R.B.T.S. Government Homoeopathic medical college and hospital

sanjaydr1981@gmail.com9304078805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026